Healthcare reform has remained a major subject of debate since President Barack Obama signed the Patient Protection and Affordable Care Act last March, but what the law means for diabetes care was the particular focus of a conference call with diabetes stakeholders Tuesday.
Infopia America last week announced that its new SmartDiabetes product line has launched in 284 Walgreens drug stores in central and northeast Florida. The central Florida Walgreens region includes stores in Jacksonville, Orlando, Lakeland, Daytona Beach and Melbourne.
A point-of-sale safety check may reduce the risk of patients unsafely receiving a drug for Type 2 diabetes that may increase their risk of heart attack, according to a new study conducted by pharmacy benefit manager Prime Therapeutics and scheduled for presentation at the 23rd annual meeting of the Academy of Managed Care Pharmacy in Minneapolis.
HealthyWage, an online network that pays members who improve their health, on Tuesday announced registration now is under way for its "Houston Matchup" competition — a citywide weight-loss contest that will reward top-performing teams with a total of $18,000 in cash prizes.
Nipro Diagnostics last month was named the South Florida Manufacturer of the Year in the 200-plus employee category by the South Florida Manufacturers Association. The award was presented March 23 at the 32nd Annual Recognition of Excellence Awards Banquet.
Patients diagnosed with high blood-glucose levels that cannot control the condition over time likely will develop such eye-related complications as retinopathy 10 years later, according to a report in the February issue of Archives of Ophthalmology.
The American Pharmacists Association Foundation announced Monday the selection of 25 companies, community health departments and other organizations — collectively known as “communities” — that will take part in the foundation’s initiative to improve care for people disproportionately affected by diabetes across the United States.
A study published online in the journal Diabetes Care, and slated for the April print issue, suggested that counting carbohydrates could lead to an improvement in quality of life and a reduction in body mass index and waist circumference in patients with Type 1 diabetes who receive continuous subcutaneous insulin infusions.
A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.
The Association of Asian Pacific Community Health Organizations has introduced a program that aims to reduce the secondary complications of diabetes among specific ethnic groups living with the disease.